BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33960737)

  • 1. Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.
    Cole CL; Bachman JF; Ye J; Murphy J; Gerber SA; Beck CA; Boyce BF; Muthukrishnan G; Chakkalakal JV; Schwarz EM; Linehan D
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):731-745. PubMed ID: 33960737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Energy X-ray Absorptiometry (DEXA) as a longitudinal outcome measure of cancer-related muscle wasting in mice.
    Cole CL; Beck CA; Robinson D; Ye J; Mills B; Gerber SA; Schwarz EM; Linehan D
    PLoS One; 2020; 15(6):e0230695. PubMed ID: 32559188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
    Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
    Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and Wasting of Skeletal Muscles in Kras-p53-Mutant Mice with Intraepithelial Neoplasia and Pancreatic Cancer-When Does Cachexia Start?
    Hildebrandt W; Keck J; Schmich S; Bonaterra GA; Wilhelm B; Schwarzbach H; Eva A; Bertoune M; Slater EP; Fendrich V; Kinscherf R
    Cells; 2022 May; 11(10):. PubMed ID: 35626644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
    Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.
    Nosacka RL; Delitto AE; Delitto D; Patel R; Judge SM; Trevino JG; Judge AR
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):820-837. PubMed ID: 32039571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 signalling is critical in the development of pancreatic cancer cachexia.
    Zhu X; Burfeind KG; Michaelis KA; Braun TP; Olson B; Pelz KR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):378-390. PubMed ID: 30666818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.
    Cheung WW; Hao S; Wang Z; Ding W; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Hoffman HM; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):120-134. PubMed ID: 31721480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
    Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
    Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated mast cells in skeletal muscle can be a potential mediator for cancer-associated cachexia.
    Widner DB; Liu C; Zhao Q; Sharp S; Eber MR; Park SH; Files DC; Shiozawa Y
    J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1079-1097. PubMed ID: 34008339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
    Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
    BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
    Kerr HL; Krumm K; Lee II; Anderson B; Christiani A; Strait L; Breckheimer BA; Irwin B; Jiang AS; Rybachok A; Chen A; Caeiro L; Dacek E; Hall DB; Kostyla CH; Hales LM; Soliman TM; Garcia JM
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1337-1348. PubMed ID: 36942661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting.
    Huang XY; Huang ZL; Yang JH; Xu YH; Sun JS; Zheng Q; Wei C; Song W; Yuan Z
    J Exp Clin Cancer Res; 2016 Mar; 35():46. PubMed ID: 26975989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.